Detection of EGFR gene mutations for prescription of targeted drugs for non-small cell lung cancer
Lung cancer is one of the most common types of cancer that occurs in both men and women. This tumor is the leading cause of death from cancer, accounting for 18.4% of the total number of deaths. Non-small cell lung cancer is the most common type of lung cancer, accounting for 85% of all cases. Withi...
Saved in:
Main Authors: | O. N. Pavlova, O. P. Bukareva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Private institution educational organization of higher education "Medical University "ReaViz"
2024-04-01
|
Series: | Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье |
Subjects: | |
Online Access: | https://vestnik.reaviz.ru/jour/article/view/912 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of the effectiveness of surgical resections following tyrosine kinase inhibitor therapy in patients with EGFR-mutated stage III–IV lung adenocarcinoma
by: E. V. Levchenko, et al.
Published: (2023-02-01) -
A Case Report of Coexistence of EGFR and ROS-1 Gene Mutations
in Non-small Cell Lung Cancer
by: Juan ZHAO, et al.
Published: (2025-06-01) -
MONITORING OF EGFR MUTATIONS IN THE CIRCULATING TUMOR DNA FROM BLOOD PLASMA OF PATIENTS WITH NON-SMALL CELL LUNG CANCER
by: V. A. Shamanin, et al.
Published: (2018-11-01) -
Interpretation of Key Points in 2024 Chinese Expert Consensus on EGFR Exon 20 Insertion Mutations in Non-Small Cell Lung Cancer
by: Xuanhong JIN, et al.
Published: (2025-06-01) -
First‐Line Osimertinib for EGFR‐Mutated Squamous Cell Lung Carcinoma: A Case Report
by: Yugo Matsumura, et al.
Published: (2025-07-01)